DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 173 filers reported holding DIPLOMAT PHARMACY INC in Q4 2016. The put-call ratio across all filers is 0.38 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $78,440,000 | -54.5% | 5,300 | -50.9% | 0.02% | -51.5% |
| Q1 2017 | $172,260,000 | -40.6% | 10,800 | -53.0% | 0.03% | -41.1% |
| Q4 2016 | $289,800,000 | -56.3% | 23,000 | -3.0% | 0.06% | -51.7% |
| Q3 2016 | $663,837,000 | -31.8% | 23,700 | -14.7% | 0.12% | -31.4% |
| Q2 2016 | $973,000,000 | +74.1% | 27,800 | +36.3% | 0.17% | +62.5% |
| Q1 2016 | $558,960,000 | -19.9% | 20,400 | 0.0% | 0.10% | -13.3% |
| Q4 2015 | $698,088,000 | -54.8% | 20,400 | -62.0% | 0.12% | -40.6% |
| Q3 2015 | $1,542,801,000 | +146.3% | 53,700 | +283.6% | 0.20% | +188.6% |
| Q2 2015 | $626,500,000 | +29.4% | 14,000 | 0.0% | 0.07% | +29.6% |
| Q1 2015 | $484,120,000 | – | 14,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 7,036,670 | $42,853,000 | 1.54% |
| ARMISTICE CAPITAL, LLC | 3,200,000 | $19,488,000 | 1.23% |
| STEPHENS INC /AR/ | 6,600,015 | $40,194,000 | 0.91% |
| S&T BANK/PA | 610,367 | $3,718,000 | 0.82% |
| Rhenman & Partners Asset Management AB | 1,203,405 | $7,329,000 | 0.81% |
| Matarin Capital Management, LLC | 701,445 | $4,272,000 | 0.30% |
| Investors Research Corp | 89,727 | $546,000 | 0.28% |
| Advisory Services Network, LLC | 598,802 | $3,647,000 | 0.22% |
| FCG ADVISORS, LLC | 34,000 | $207,000 | 0.06% |
| EVERENCE CAPITAL MANAGEMENT INC | 52,730 | $321,000 | 0.05% |